8B60.0ICD-11 MMS 2026-01
Amyotrophic lateral sclerosis
Description
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disorder in which progressive signs of LMN and UMN degeneration are seen within one or more of the four regions: bulbar, cervical, thoracic and lumbosacral. Electrophysiological studies may be required to confirm lower motor neuron degeneration and to exclude alternative causes. Neuroimaging may be performed to exclude other causes, which might explain the clinical and electrophysiological features. Familial ALS (FALS) of autosomal dominant inheritance constitutes 5 to 10% of ALS. The clinical profile of FALS and sporadic ALS is similar. Mutations in the C9ORF72 and Cu/Zn superoxide dismutase (SOD1) genes constitute 50-60% of FALS.
Index terms
- Amyotrophic lateral sclerosis
- ALS - [amyotrophic lateral sclerosis]
- amyotrophic paralysis
Show allHide
- amyotrophic sclerosis
- amyotrophy lateral sclerosis
- progressive atrophic paralysis
- spinal progressive amyotrophy
Exclusions from above levels
05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth and the puerperium19– Certain conditions originating in the perinatal period
Show allHide
22– Injury, poisoning or certain other consequences of external causes
Sibling codes
8B60.1– Progressive bulbar palsy8B60.2– Progressive pseudobulbar palsy8B60.3– Progressive muscular atrophy8B60.4– Primary lateral sclerosis8B60.5– Amyotrophic lateral sclerosis-Plus8B60.6– Monomelic amyotrophy8B60.7– Madras type motor neuron disease8B60.Y– Other specified motor neuron disease8B60.Z– Motor neuron disease, unspecified
Foundation entity
Amyotrophic lateral sclerosis – http://id.who.int/icd/entity/1982355687
Allowed postcoordination axes
Part of: 8B60: Motor neuron disease › 08: Diseases of the nervous system